Online Peer Support for Caregivers of Lewy Body Dementia

(VOCALE LBD Trial)

OZ
Overseen ByOleg Zaslavsky, PhD, RN
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Washington
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study tests whether a tailored, fully asynchronous online group intervention (VOCALE LBD) reduces depression in family caregivers of people with Lewy Body Dementia (LBD), compared to standard educational materials. LBD is the second most common form of degenerative dementia and causes distinct challenges, including visual hallucinations, REM sleep disorder, and severe motor symptoms, that are not addressed by generic caregiver interventions. Depression rates in LBD caregivers reach 40-50%, double the rate seen in Alzheimer's disease caregivers, yet no rigorous digital interventions exist specifically for this population. VOCALE LBD is a text-based, low-bandwidth platform (Discourse) that brings groups of 10-15 caregivers together in an 8-week moderated online community. Weekly topics address LBD-specific challenges (sleep problems, hallucinations, self-care) and problem-solving skills using the ADAPT method. A pilot study (n=54) showed strong effects on depressive symptoms (Cohen's d=0.54 at 1-month follow-up), near-perfect engagement, and high participant satisfaction. This RCT (N=220) will test efficacy, examine mechanisms of action (self-efficacy and problem-solving), and explore analytics approaches for pragmatic monitoring, laying groundwork for future implementation in clinics and community organizations.

Are You a Good Fit for This Trial?

This trial is for family caregivers of people with Lewy Body Dementia who may be experiencing stress or depression. Participants should have internet access and be able to join an online group. There are no detailed exclusion criteria listed.

Inclusion Criteria

I have a PHQ-9 depression score of 5 or higher.
Able to read, write, and speak English
Current family member or informal (unpaid) caregiver of a person with a confirmed diagnosis of Lewy Body Dementia (LBD) or LBD mixed pathology
See 1 more

Exclusion Criteria

Active suicidal ideation as indicated by endorsement of PHQ-9 Item 9 (thoughts that you would be better off dead, or thoughts of hurting yourself)
Paid or professional caregiver (must be unpaid family/informal caregiver)
Unable to read, write, or speak English

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in an 8-week, fully asynchronous, text-based online group intervention (VOCALE LBD) addressing LBD-specific challenges and problem-solving skills

8 weeks
Online participation, no in-person visits required

Follow-up

Participants are monitored for sustained effects on depressive symptoms and other outcomes

6 months
Assessments at post-intervention and 6-month follow-up

What Are the Treatments Tested in This Trial?

Interventions

  • VOCALE LBD: Virtual Online Communities for Aging Life Experiences: Lewy Body Dementia

Trial Overview

The study compares an 8-week, moderated online support group (VOCALE LBD) designed specifically for LBD caregivers against standard educational materials. The goal is to see if the online group helps reduce caregiver depression more effectively.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: VOCALE LBDExperimental Treatment1 Intervention
Group II: Standard of CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Washington

Lead Sponsor

Trials
1,858
Recruited
2,023,000+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

The Lewy Body Dementia Association (LBDA)

Collaborator

Trials
1
Recruited
230+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+